The University of Minnesota Masonic Cancer Center (MCC) has been awarded an outstanding rating by the National Cancer Institute (NCI). The rating represents its highest rating to date. MCC also renewed its five-year Cancer Center Support Grant, which allows the center to continue its groundbreaking research in the areas of cancer, cancer prevention, survivorship, tobacco control research, and innovative strategies to treat cancer including immuno- and cellular therapies. 

The NCI has 70 NCI-Designated Cancer Centers across the nation. Since 1998, the Masonic Cancer Center has been the only one in the Twin Cities and continues to be a national leader in cancer research and patient care.

“As cancer physicians and researchers, our goal is to change cancer in the same way tuberculosis was changed a generation ago,” said Jakub Tolar, MD, PhD, Dean of the Medical School. “We achieve this by combining innovation and care delivery in a way that improves the outcomes of the disease. The continued success of the Masonic Cancer Center shows the value of our work, as well as the skill and expertise we offer in cancer research, prevention, and treatment.”